The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 28, 2017

Filed:

Jul. 20, 2012
Applicants:

Douglas R. Savage, Del Mar, CA (US);

John E. Shulze, Rancho Santa Margarita, CA (US);

Ronald E. Betts, La Jolla, CA (US);

Sepehr Fariabi, Newport Coast, CA (US);

Shih-horng Su, Irvine, CA (US);

Inventors:

Douglas R. Savage, Del Mar, CA (US);

John E. Shulze, Rancho Santa Margarita, CA (US);

Ronald E. Betts, La Jolla, CA (US);

Sepehr Fariabi, Newport Coast, CA (US);

Shih-Horng Su, Irvine, CA (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61F 2/82 (2013.01); A61L 31/02 (2006.01); A61F 2/91 (2013.01); A61F 2/915 (2013.01); A61L 31/16 (2006.01); A61F 2/848 (2013.01); A61F 2/89 (2013.01);
U.S. Cl.
CPC ...
A61L 31/022 (2013.01); A61F 2/91 (2013.01); A61F 2/915 (2013.01); A61L 31/16 (2013.01); A61F 2/82 (2013.01); A61F 2/848 (2013.01); A61F 2/89 (2013.01); A61F 2002/825 (2013.01); A61F 2002/91541 (2013.01); A61F 2210/0004 (2013.01); A61F 2210/0014 (2013.01); A61F 2220/0025 (2013.01); A61F 2230/0013 (2013.01); A61F 2250/0023 (2013.01); A61F 2250/0025 (2013.01); A61F 2250/0026 (2013.01); A61F 2250/0036 (2013.01); A61F 2250/0037 (2013.01); A61F 2250/0051 (2013.01); A61F 2250/0067 (2013.01); A61F 2250/0068 (2013.01); A61F 2250/0096 (2013.01); A61L 2300/416 (2013.01); A61L 2300/606 (2013.01);
Abstract

An improvement in drug-eluting stents, and method of their making, are disclosed. The surface of a metal stent is roughened to have a surface roughness of at least about 20 μin (0.5 μm) and a surface roughness range of between about 300-700 μin (7.5-17.5 μm). The roughened stent surface is covered with a polymer-free coating of a limus drug, to a coating thickness greater than the range of surface roughness of the roughened stent surface.


Find Patent Forward Citations

Loading…